 RATIONALE: Comparing results of MRI scans done after bevacizumab may help doctors predict a patients response to treatment and help plan the best treatment. It is not yet known whether giving bevacizumab alone is more effective than giving bevacizumab together with interferon alpha-2a in detecting kidney cancer. 